Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Investors looking for solid income amidst the recent market turmoil should consider Holly Energy Partners, L.P. (HEP - Snapshot Report). The partnership pays a distribution that yields a stellar 6.9%. It has increased this distribution a remarkable 27 consecutive quarters dating back to its IPO in 2004.
HEP also recently reported a solid second quarter in which earnings per limited partner unit came in 13% above the Zacks Consensus Estimate. Analysts have been raising their estimates off of the strong quarter, sending the stock to a Zacks #2 Rank (Buy).
Master Limited Partnership
Holly Energy Partners is a master limited partnership (MLP) that operates petroleum product and crude oil pipelines, storage tanks, distribution terminals, and loading rack facilities. As an MLP, it must distribute at least 90% of its income to unitholders to avoid taxation on that money.
It is headquartered in Dallas, Texas and has a market cap of $1.1 billion.
Second Quarter Results
Holly Energy Partners reported second quarter results on July 28. Earnings per limited partner unit came in at 69 cents, well ahead of the Zacks Consensus Estimate of 61 cents. It was a 42% increase over the same quarter in 2010.
Revenue rose 12% year-over-year to $50.9 million, well ahead of the Zacks Consensus Estimate of $48.0 million. The increase was driven by higher refined product pipelines revenue as shipments increased to an average of 142.6 thousand barrels per day compared with 133.3 thousand in the same quarter last year.
Overall pipeline volumes increased a solid 7%.
Operating expenses as a percentage of total revenues declined from 50.6% to 46.4% as the company leveraged its fixed costs. This helped drive a 21% increase in operating income year-over-year.
Outlook
Analysts mostly raised their earnings estimates for both 2011 and 2012 off of the solid quarter, sending the stock to a Zacks #2 Rank (Buy).
Analysts are projecting strong growth for HEP over the next two years. The 2011 Zacks Consensus Estimate is $2.55, representing 20% growth over 2010. The 2012 consensus estimate is currently $2.75, corresponding with 8% earnings growth.
Distribution
On top of this growth, HEP pays a distribution that yields a juicy 6.9%. The partnership has raised it a remarkable 27 consecutive quarters since going public in 2004 at an average annual rate of 7.5%.
Valuation
The valuation picture looks reasonable for this MLP. It trades at 19.4x 12-month forward earnings, in-line with both the industry average and its 10-year median.
The Bottom Line
HEP provides much needed stability for investors with its solid 6.9% distribution yield. With earnings estimates rising and valuation still reasonable, it just might provide some capital appreciation too.
Todd Bunton is the Growth & Income Stock Strategist for Zacks Investment Research.
Get the full Snapshot Report on HEP - FREE